{"gene":"ABCD3","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":1993,"finding":"PMP70 (ABCD3) was identified as an ATP-binding cassette (ABC) transporter localized to the peroxisomal membrane, with a domain structure comprising six transmembrane segments and a hydrophilic ATP-binding domain homologous to other ABC transporters, suggesting involvement in ATP-dependent transport across the peroxisomal membrane.","method":"cDNA cloning and hydropathy analysis of rat and human liver cDNA libraries","journal":"Nihon rinsho. Japanese journal of clinical medicine","confidence":"Medium","confidence_rationale":"Tier 2 — foundational cDNA cloning with structural domain identification; single lab","pmids":["8411712"],"is_preprint":false},{"year":1998,"finding":"The human PMP70 gene (PXMP1/ABCD3) was mapped to chromosome 1p21-p22, spans ~65 kb with 23 exons, and its promoter contains housekeeping gene features (high GC content, Sp1 sites) but no peroxisome proliferator responsive element, distinguishing it structurally from the related ALD gene.","method":"Genomic cloning, exon-intron mapping, 5' flanking region analysis, chromosomal localization","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 — direct genomic characterization; single lab","pmids":["9521874"],"is_preprint":false},{"year":1998,"finding":"Overexpression of PMP70 (ABCD3) restores peroxisome biogenesis in PEX2-deficient CHO cell clones, as confirmed by subcellular latency of catalase, immunolocalization of catalase, and beta-oxidation of very long chain fatty acids; a Zellweger syndrome-associated mutant allele of PMP70 failed to rescue, indicating a functional interaction between PEX2 and PMP70 in peroxisome membrane assembly.","method":"Transfection rescue experiments in PEX2-mutant CHO cells; catalase latency assay; immunohistochemistry; VLCFA beta-oxidation assay","journal":"European journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal functional assays with mutant allele control; single lab but rigorous","pmids":["9765053"],"is_preprint":false},{"year":2000,"finding":"PMP70 (ABCD3) is synthesized on free polysomes and posttranslationally inserted into peroxisomal membranes, where it assembles as dimeric or oligomeric forms, consistent with a role in long-chain acyl-CoA transport across the peroxisomal membrane.","method":"Cell fractionation, immunoblot, and biochemical characterization of peroxisomal membranes","journal":"Cell biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 2 — direct biochemical fractionation evidence; single review-style paper synthesizing experimental work","pmids":["11330039"],"is_preprint":false},{"year":2001,"finding":"Efficient peroxisomal targeting of human PMP70 (ABCD3) requires three targeting elements in the amino-terminal region: amino acids 61–80 in the cytosol, and the first and second transmembrane domains; PEX19 interaction is not required for targeting.","method":"Expression of deletion constructs in CHO cells; immunofluorescence localization","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct localization experiments with deletion constructs; single lab","pmids":["11453642"],"is_preprint":false},{"year":2002,"finding":"PMP70 (ABCD3) binds ATP tightly in the absence of Mg2+; in the presence of Mg2+, bound ATP is hydrolyzed to ADP which then dissociates, enabling ATPase turnover. PMP70 is also phosphorylated at a tyrosine residue(s). Vanadate-induced nucleotide trapping was not observed, distinguishing its mechanism from some other ABC transporters.","method":"Photoaffinity labeling of rat liver peroxisomes with 8-azido-[α-32P]ATP and 8-azido-[γ-32P]ATP; co-immunoprecipitation; Mg2+-dependent hydrolysis assay; vanadate trapping assay; phosphorylation detection","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro biochemical reconstitution with multiple nucleotide analogs and controls; rigorous mechanistic dissection","pmids":["12176987"],"is_preprint":false},{"year":2002,"finding":"ATP binding to PMP70 (ABCD3) induces nucleotide-dependent conformational changes detectable by limited trypsin digestion: MgATP or MgADP stabilize a ~30 kDa C-terminal fragment spanning the helical domain between Walker A and B motifs, while MgATP-γS protects the entire protein. The C-terminal fragment forms an ~60 kDa complex consistent with PMP70 dimerization on peroxisomal membranes.","method":"Limited trypsin digestion of rat liver peroxisomes pre-incubated with various nucleotides; immunoblot with anti-C-terminal antibody; gel filtration","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — in vitro structural/conformational assay with multiple nucleotide conditions; directly links ATP hydrolysis to conformational change","pmids":["11883951"],"is_preprint":false},{"year":2004,"finding":"Mouse liver PMP70 (ABCD3) forms predominantly homomeric complexes in vivo; no evidence of heteromeric interactions with ALDP (ABCD1) or accessory proteins was found under normal physiological expression conditions.","method":"Two-step purification of PMP70 protein complex to homogeneity; preparative immunoprecipitation of ALDP complex; protein identification","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 2 — protein complex purified to homogeneity from native tissue; reciprocal IP; strong evidence for homodimerization","pmids":["15276650"],"is_preprint":false},{"year":2005,"finding":"Pex19p acts as a chaperone for PMP70 (ABCD3) during synthesis, binding co-translationally to prevent aggregation; the interaction requires both the N-terminal 61 amino acids and the region around TMD6 of PMP70, and deletion of either region abolishes peroxisomal localization.","method":"In vitro translation with purified Pex19p; co-immunoprecipitation; GFP fusion constructs expressed in CHO cells; immunofluorescence localization","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 2 — in vitro reconstitution of chaperone interaction combined with cell-based localization assays; multiple deletion constructs","pmids":["16344115"],"is_preprint":false},{"year":2007,"finding":"In living cells, ALDP (ABCD1) and PMP70 (ABCD3) form both homodimers and heterodimers (ALDP/PMP70) in the peroxisomal membrane, with ALDP homodimers predominating. The last 87 C-terminal amino acids of ALDP constitute the primary dimerization domain, with the N-terminal transmembrane region providing additional stabilization of ALDP homodimers.","method":"FRET microscopy in intact living cells; probability distribution shift analysis; Kolmogorov-Smirnov statistics; C-terminal deletion constructs of ALDP","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — live-cell FRET with rigorous statistical analysis; circumvents in vitro artifacts; multiple deletion constructs","pmids":["17609205"],"is_preprint":false},{"year":2008,"finding":"Knockdown of PMP70 (ABCD3) in rat C6 glial cells impairs peroxisomal beta-oxidation and causes oxidative stress (elevated nitric oxide via iNOS upregulation, increased superoxide and lipid peroxidation, altered antioxidant enzyme activities). The resulting oxidative phenotype is dependent on IL-12 release rather than being a direct consequence of PMP70 loss.","method":"Stable RNAi knockdown of ABCD3 in C6 cells; nitrite measurement; superoxide and TBARS assays; antioxidant enzyme activity; cytokine quantification; neutralizing antibodies against IL-12","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 2–3 — stable KD with multiple phenotypic readouts and pathway dissection using neutralizing antibodies; single lab","pmids":["18992293"],"is_preprint":false},{"year":2009,"finding":"The N-terminal 80-amino-acid segment (N80) of PMP70 (ABCD3) is critical for suppressing the intrinsic ER-targeting function of the TM1 segment: TM1 alone directs protein to the ER, the N80 segment alone targets mitochondrial outer membrane, but together N80 + TM1-TM2 directs exclusively to peroxisomes. Cooperation of multiple organelle-targeting signals enables correct peroxisomal localization.","method":"EGFP fusion constructs expressed in COS cells; fluorescence microscopy; deletion and domain-swap analysis","journal":"Journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 — systematic domain analysis with multiple constructs and direct imaging; single lab","pmids":["20007743"],"is_preprint":false},{"year":2013,"finding":"ABCD3 (PMP70) transports long-chain unsaturated, long branched-chain, and long-chain dicarboxylic fatty acids (as CoA esters) into peroxisomes for beta-oxidation, with a substrate preference distinct from ABCD1 (favoring C24:0/C26:0) and ABCD2 (favoring C22:0/C22:6). Each peroxisomal half-transporter can function as a homodimer, demonstrated by partial rescue of the pxa1/pxa2Δ yeast mutant by human ABCD3.","method":"Functional complementation of pxa1/pxa2Δ yeast mutant; fatty acid oxidation measurements with multiple substrates in yeast expressing human ABCD transporters","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in yeast combined with comprehensive substrate specificity profiling; mechanistically rigorous","pmids":["24333844"],"is_preprint":false},{"year":2014,"finding":"ABCD3 is essential for peroxisomal transport of branched-chain fatty acids (e.g., pristanic acid) and C27 bile acid intermediates, making it a crucial step in bile acid biosynthesis. Loss of ABCD3 (patient with truncating mutation p.Y635NfsX1; Abcd3−/− mice) causes accumulation of C27-bile acid intermediates, reduced C24 bile acids, and reduced pristanic acid beta-oxidation, with peroxisomes remaining import-competent but reduced in number and enlarged.","method":"Patient fibroblast analysis; genetic analysis; Abcd3−/− mouse model; bile acid profiling in liver, bile and intestine; phytol loading assay; peroxisomal beta-oxidation assays","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — human patient + mouse KO model with multiple biochemical endpoints; independently validated in two biological systems","pmids":["25168382"],"is_preprint":false},{"year":2015,"finding":"A short N-terminal sequence of nine residues in PMP70 (ABCD3), specifically Ser5, acts as an ER-targeting suppressor by blocking the intrinsic ER-targeting signal of the TM1 segment. The Ser5Ala point mutation causes PMP70 to localize predominantly to the ER. Two proteins of ~50 kDa and ~20 kDa crosslink with this suppressor motif.","method":"Point mutagenesis (Ser5Ala); fluorescence microscopy in COS cells; crosslinking to identify binding proteins; recombinant motif-GST competition assay","journal":"Journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 1–2 — point mutagenesis with direct localization readout and crosslinking; single lab","pmids":["26711236"],"is_preprint":false},{"year":2018,"finding":"Peroxisomes can oxidize medium- and long-chain fatty acids (lauric and palmitic acid) through a pathway requiring both ABCD3 and HSD17B4 (D-bifunctional protein). Peroxisomes accept acylcarnitines (not only acyl-CoAs) as substrates. This peroxisomal pathway becomes physiologically relevant when mitochondrial FAO is defective, as demonstrated in vivo by altered plasma acylcarnitine profiles in Hsd17b4 KO mice after acute CPT2 inhibition.","method":"CRISPR-Cas9 single and double KO of ABCD3, HSD17B4, and CPT2 in HEK-293 cells; pharmacological CPT2 inhibition; acylcarnitine profiling; Hsd17b4 KO mouse model with CPT2 inhibition","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — CRISPR KO with multiple single/double KO cell lines plus in vivo mouse validation; two independent experimental systems","pmids":["30540494"],"is_preprint":false},{"year":2021,"finding":"ABCD3 interacts with INTS7 in bone marrow mesenchymal stem cells; this INTS7-ABCD3 interaction promotes BM-MSC proliferation and osteoblastic differentiation while suppressing adipogenic differentiation, through suppression of oxidative stress (reduced ROS and γ-H2AX, maintained antioxidant levels). HDLBP, also identified as an ABCD3 interactor, did not share these functions.","method":"Co-immunoprecipitation (INTS7-ABCD3 interaction); siRNA knockdown of INTS7, ABCD3, and HDLBP; ROS quantification; γ-H2AX measurement; Alizarin Red S and Oil Red O staining for differentiation; apoptosis assays","journal":"Frontiers in physiology","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP identifies interaction; functional KD with multiple readouts; single lab","pmids":["34880777"],"is_preprint":false},{"year":2024,"finding":"CCG repeat expansions in ABCD3 (118–694 repeats) cause oculopharyngodistal myopathy (OPDM) in individuals of European ancestry; ABCD3 transcript appears upregulated in fibroblasts and skeletal muscle from affected individuals, suggesting gain-of-function RNA toxicity as a disease mechanism.","method":"Repeat expansion genotyping; long-read sequencing; RT-qPCR of ABCD3 transcript levels in patient fibroblasts and skeletal muscle","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 3 — genetic identification with transcript upregulation evidence; mechanism (RNA toxicity) is inferred rather than directly proven","pmids":["39068203"],"is_preprint":false},{"year":2025,"finding":"The VCP-FAF2 complex prevents excessive pexophagy by regulating the accumulation of ubiquitinated ABCD3; loss of FAF2 or inhibition of VCP increases ubiquitination of ABCD3 and drives peroxisome degradation via selective autophagy (pexophagy), which can be rescued by USP30 overexpression or depletion of autophagy receptors.","method":"VCP inhibition and FAF2 knockout; quantitative proteomics; ubiquitination assays for ABCD3; autophagy flux assays; USP30 overexpression rescue","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and pharmacological perturbation with proteomic validation; mechanistically links ABCD3 ubiquitination to pexophagy","pmids":["39929145"],"is_preprint":false},{"year":2025,"finding":"ABCD3 depletion in colorectal cancer cells reduces cell viability, proliferation, invasion, and migration; mechanistically, ABCD3 suppresses Wnt/β-catenin signaling, and its loss activates this pathway to promote malignant behavior. ABCD3 protein also protects against excessive lipid peroxidation and maintains neutral lipid and lipid droplet homeostasis in cancer cells.","method":"siRNA knockdown; CCK-8 proliferation assay; Transwell invasion/migration assay; Western blot; TCGA/WGCNA bioinformatics; lipid peroxidation assays; neutral lipid staining","journal":"Molecular biology reports / Cell death & disease","confidence":"Low","confidence_rationale":"Tier 3 — KD with phenotypic readouts and pathway inference; Wnt/β-catenin link is functional but molecular mechanism not directly established","pmids":["40668324","40229252"],"is_preprint":false},{"year":2025,"finding":"Cryo-EM structures of full-length human ABCD3 in apo (3.33 Å) and phytanoyl-CoA-bound (3.13 Å) states reveal that substrate binding brings the two nucleotide-binding domains (NBDs) closer together, mechanistically explaining how substrate binding stimulates ATPase activity. Biochemical assays confirm substrate-dependent ATPase activation.","method":"Cryo-EM structure determination; ATPase activity biochemical assay; structural comparison of apo vs. substrate-bound conformations","journal":"bioRxiv (preprint)","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM structures of both states plus functional ATPase assay; rigorous mechanistic study","pmids":["bio_10.1101_2025.05.21.655323"],"is_preprint":true},{"year":2025,"finding":"Edited miR-579-3p (A-to-I editing) acquires ABCD3 as a novel target, suppressing ABCD3-mediated VLCFA beta-oxidation in astrocytes and thereby exacerbating hypoxic-ischemic brain damage; wild-type miR-579-3p does not target ABCD3.","method":"Dual-luciferase reporter assay confirming miRNA-ABCD3 3'UTR interaction; VLCFA measurement by ELISA; Western blot and RT-qPCR; in vivo HIBD mouse model","journal":"Neurological research","confidence":"Medium","confidence_rationale":"Tier 2 — luciferase reporter validates direct miRNA-ABCD3 targeting; in vivo confirmation; single lab","pmids":["40937863"],"is_preprint":false}],"current_model":"ABCD3 (PMP70) is a peroxisomal membrane half-ABC transporter that homodimerizes (and can heterodimerize with ABCD1) to transport branched-chain fatty acids, long-chain dicarboxylic acids, and C27 bile acid intermediates as CoA esters into the peroxisome for beta-oxidation and bile acid biosynthesis; substrate binding induces NBD dimerization to stimulate ATP hydrolysis (now structurally resolved by cryo-EM), its peroxisomal targeting depends on an N-terminal ER-suppressor motif and Pex19p chaperone interaction, and its protein quality is controlled by VCP-FAF2-mediated regulation of ubiquitination to prevent excessive pexophagy."},"narrative":{"teleology":[{"year":1993,"claim":"Identifying ABCD3 as a peroxisomal ABC transporter established the gene family context and predicted ATP-dependent transport across the peroxisomal membrane.","evidence":"cDNA cloning and hydropathy analysis from rat and human liver libraries","pmids":["8411712"],"confidence":"Medium","gaps":["No transport substrate identified","No functional assay performed","Domain architecture inferred from homology only"]},{"year":2002,"claim":"Biochemical dissection of ATP binding and hydrolysis revealed that ABCD3 requires Mg²⁺ for ATPase turnover and undergoes nucleotide-dependent conformational changes consistent with a dimeric catalytic mechanism, distinguishing it from vanadate-trappable ABC transporters.","evidence":"Photoaffinity labeling with azido-ATP analogs, limited trypsinolysis with multiple nucleotides, and gel filtration of rat liver peroxisomes","pmids":["12176987","11883951"],"confidence":"High","gaps":["No transport substrate identified at this stage","ATPase assay performed on endogenous membranes rather than reconstituted protein","Dimerization stoichiometry inferred from fragment size on gel filtration"]},{"year":2004,"claim":"Purification of native PMP70 complexes from mouse liver demonstrated that ABCD3 predominantly forms homodimers in vivo, resolving the question of whether it required ABCD1 as a heterodimerization partner.","evidence":"Two-step purification to homogeneity and reciprocal immunoprecipitation of ALDP complexes from mouse liver","pmids":["15276650"],"confidence":"High","gaps":["Heterodimerization with ABCD1 not excluded under all conditions","Functional significance of homodimer versus heterodimer not tested"]},{"year":2005,"claim":"Establishing that Pex19p chaperones nascent ABCD3 co-translationally to prevent aggregation answered how a polytopic membrane protein reaches the peroxisome post-translationally.","evidence":"In vitro translation with purified Pex19p, co-immunoprecipitation, and GFP-fusion localization in CHO cells","pmids":["16344115"],"confidence":"High","gaps":["Identity of the membrane insertion machinery at the peroxisome not resolved","Whether Pex19p is strictly required or facilitatory was debated across studies"]},{"year":2007,"claim":"Live-cell FRET confirmed ABCD3 forms both homodimers and heterodimers with ABCD1 in intact peroxisomal membranes, refining the earlier homodimer-only model and raising questions about heterodimer-specific substrate channeling.","evidence":"FRET microscopy with statistical probability-distribution analysis in living cells; C-terminal deletion mapping of dimerization domains","pmids":["17609205"],"confidence":"High","gaps":["Functional consequences of heterodimerization not determined","Relative abundance of heterodimers versus homodimers in different tissues unknown"]},{"year":2009,"claim":"Systematic domain-swap experiments revealed that the N-terminal 80-residue segment suppresses an intrinsic ER-targeting signal in TM1, explaining how ABCD3 escapes the secretory pathway to reach peroxisomes.","evidence":"EGFP fusion constructs with deletions and domain swaps expressed in COS cells; fluorescence microscopy","pmids":["20007743"],"confidence":"Medium","gaps":["Cytosolic factors recognizing the suppressor motif not identified at this stage","Mechanism by which TM1 alone targets ER not resolved"]},{"year":2013,"claim":"Functional complementation of yeast pxa1/pxa2Δ mutants with human ABCD3 defined its substrate preference for branched-chain, long-chain unsaturated, and dicarboxylic fatty acyl-CoAs, distinguishing ABCD3 from ABCD1 and ABCD2.","evidence":"β-oxidation assays with multiple fatty acid substrates in yeast expressing individual human ABCD transporters","pmids":["24333844"],"confidence":"High","gaps":["Direct transport assay with purified protein not performed","In vivo substrate hierarchy in mammals not established"]},{"year":2014,"claim":"Human patient and mouse knockout studies proved ABCD3 is essential for peroxisomal import of C27 bile acid intermediates and pristanic acid, linking ABCD3 loss to a defined metabolic disease with bile acid accumulation.","evidence":"Fibroblast analysis from patient with truncating ABCD3 mutation; Abcd3−/− mice with bile acid profiling and phytol loading","pmids":["25168382"],"confidence":"High","gaps":["Full clinical spectrum of ABCD3 deficiency not delineated","Whether residual transport occurs via ABCD1/ABCD2 compensation not quantified"]},{"year":2015,"claim":"Pinpointing Ser5 as the critical residue in the ER-suppressor motif showed that a single amino acid substitution reroutes ABCD3 to the ER, narrowing the targeting code to a defined molecular determinant.","evidence":"Ser5Ala point mutagenesis with fluorescence microscopy in COS cells; crosslinking to identify ~50 kDa and ~20 kDa binding partners","pmids":["26711236"],"confidence":"Medium","gaps":["Identity of the ~50 kDa and ~20 kDa crosslinked proteins not determined","Whether Ser5 phosphorylation regulates targeting not tested"]},{"year":2018,"claim":"Demonstrating that peroxisomes accept acylcarnitines via ABCD3/HSD17B4 and compensate for mitochondrial FAO deficiency expanded the physiological scope of ABCD3 from bile acid/branched-chain metabolism to medium/long-chain fatty acid oxidation.","evidence":"CRISPR-Cas9 single and double KO in HEK-293 cells; CPT2 inhibition; acylcarnitine profiling; Hsd17b4 KO mouse with CPT2 inhibition","pmids":["30540494"],"confidence":"High","gaps":["Whether ABCD3 directly transports acylcarnitines or CoA-converted intermediates not resolved","Tissue specificity of this compensatory pathway not fully mapped"]},{"year":2024,"claim":"Discovery of CCG repeat expansions in ABCD3 as a cause of oculopharyngodistal myopathy established a second distinct disease mechanism (repeat expansion/RNA toxicity) separate from loss-of-function metabolic disease.","evidence":"Repeat expansion genotyping, long-read sequencing, RT-qPCR of ABCD3 transcript in patient fibroblasts and muscle","pmids":["39068203"],"confidence":"Medium","gaps":["RNA toxicity mechanism not directly demonstrated","Whether ABCD3 protein function is altered by repeat expansion not tested","Replication in larger cohorts needed"]},{"year":2025,"claim":"VCP–FAF2-mediated regulation of ABCD3 ubiquitination was shown to control peroxisome abundance by preventing excessive pexophagy, establishing ABCD3 as a key ubiquitination target in peroxisome quality control.","evidence":"VCP inhibition and FAF2 KO with quantitative proteomics, ubiquitination assays, and USP30 rescue","pmids":["39929145"],"confidence":"Medium","gaps":["Specific ubiquitination sites on ABCD3 not mapped","Whether ubiquitinated ABCD3 is directly recognized by autophagy receptors not resolved"]},{"year":2025,"claim":"Cryo-EM structures of apo and phytanoyl-CoA-bound ABCD3 revealed that substrate binding brings the two NBDs closer together, providing the structural basis for substrate-stimulated ATPase activity and completing the transport cycle model.","evidence":"Cryo-EM at 3.1–3.3 Å resolution of full-length human ABCD3; ATPase assay (preprint)","pmids":["bio_10.1101_2025.05.21.655323"],"confidence":"High","gaps":["Structures of nucleotide-bound and post-hydrolysis states not yet captured","Mechanism of substrate release into the peroxisomal lumen not resolved","Preprint — awaits peer review"]},{"year":null,"claim":"Key unresolved questions include the structural basis of the complete transport cycle (nucleotide-bound and outward-open states), the identity of cytosolic factors that interact with the Ser5 ER-suppressor motif, the functional significance of ABCD1–ABCD3 heterodimers versus homodimers in different tissues, and the molecular mechanism of RNA toxicity in ABCD3 repeat expansion disease.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Full transport cycle intermediates not structurally resolved","Tissue-specific roles of heterodimer versus homodimer unknown","RNA toxicity mechanism in OPDM not directly demonstrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[5,6,20]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[12,13,15]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[5,6,20]}],"localization":[{"term_id":"GO:0005777","term_label":"peroxisome","supporting_discovery_ids":[0,3,4,7,8,9,11]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[12,13,15]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[5,6,12,13,20]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[18]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[2,18]}],"complexes":["ABCD3 homodimer","ABCD1-ABCD3 heterodimer"],"partners":["ABCD1","PEX19","PEX2","HSD17B4","VCP","FAF2","USP30","INTS7"],"other_free_text":[]},"mechanistic_narrative":"ABCD3 (PMP70) is a peroxisomal membrane ABC half-transporter that homodimerizes to import branched-chain fatty acids, long-chain dicarboxylic acids, and C27 bile acid intermediates as CoA esters into the peroxisome for β-oxidation and bile acid biosynthesis [PMID:24333844, PMID:25168382]. ATP binding induces nucleotide-binding domain dimerization and conformational changes that drive an ATPase cycle with substrate-stimulated hydrolysis; Mg²⁺ is required for catalytic turnover, and substrate binding brings the two NBDs closer together to activate ATPase activity [PMID:12176987, PMID:11883951]. Correct peroxisomal targeting depends on an N-terminal ER-suppressor motif (notably Ser5) cooperating with the first two transmembrane domains, and on co-translational chaperoning by Pex19p, while protein quality is maintained by VCP–FAF2-mediated regulation of ABCD3 ubiquitination that prevents excessive pexophagy [PMID:26711236, PMID:16344115, PMID:39929145]. Loss-of-function mutations in ABCD3 cause accumulation of C27-bile acid intermediates and impaired pristanic acid oxidation in humans and mice, and CCG repeat expansions in ABCD3 cause oculopharyngodistal myopathy [PMID:25168382, PMID:39068203]."},"prefetch_data":{"uniprot":{"accession":"P28288","full_name":"ATP-binding cassette sub-family D member 3","aliases":["70 kDa peroxisomal membrane protein","PMP70"],"length_aa":659,"mass_kda":75.5,"function":"Broad substrate specificity ATP-dependent transporter of the ATP-binding cassette (ABC) family that catalyzes the transport of long-chain fatty acids (LCFA)-CoA, dicarboxylic acids-CoA, long-branched-chain fatty acids-CoA and bile acids from the cytosol to the peroxisome lumen for beta-oxydation (PubMed:11248239, PubMed:24333844, PubMed:25168382, PubMed:29397936). Has fatty acyl-CoA thioesterase and ATPase activities (PubMed:29397936). Probably hydrolyzes fatty acyl-CoAs into free fatty acids prior to their ATP-dependent transport into peroxisomes (By similarity). Thus, play a role in regulation of LCFAs and energy metabolism namely, in the degradation and biosynthesis of fatty acids by beta-oxidation (PubMed:24333844, PubMed:25944712)","subcellular_location":"Peroxisome membrane","url":"https://www.uniprot.org/uniprotkb/P28288/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ABCD3","classification":"Not Classified","n_dependent_lines":25,"n_total_lines":1208,"dependency_fraction":0.020695364238410598},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CALM1","stoichiometry":0.2},{"gene":"CALM2","stoichiometry":0.2},{"gene":"CALM3","stoichiometry":0.2},{"gene":"PEX3","stoichiometry":0.2},{"gene":"RAB2A","stoichiometry":0.2},{"gene":"SAE1","stoichiometry":0.2},{"gene":"UBA1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ABCD3","total_profiled":1310},"omim":[{"mim_id":"621446","title":"OCULOPHARYNGODISTAL MYOPATHY 5; OPDM5","url":"https://www.omim.org/entry/621446"},{"mim_id":"616278","title":"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5","url":"https://www.omim.org/entry/616278"},{"mim_id":"614593","title":"MEIOSIS REGULATOR AND mRNA STABILITY FACTOR 1; MARF1","url":"https://www.omim.org/entry/614593"},{"mim_id":"614362","title":"ACYL-CoA SYNTHETASE, BUBBLEGUM FAMILY, MEMBER 1; ACSBG1","url":"https://www.omim.org/entry/614362"},{"mim_id":"609501","title":"TUDOR AND KH DOMAINS-CONTAINING PROTEIN; TDRKH","url":"https://www.omim.org/entry/609501"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Peroxisomes","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":118.4}],"url":"https://www.proteinatlas.org/search/ABCD3"},"hgnc":{"alias_symbol":["PMP70","ZWS2"],"prev_symbol":["PXMP1"]},"alphafold":{"accession":"P28288","domains":[{"cath_id":"-","chopping":"226-403","consensus_level":"medium","plddt":86.3976,"start":226,"end":403},{"cath_id":"3.40.50.300","chopping":"431-648","consensus_level":"high","plddt":91.6647,"start":431,"end":648}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P28288","model_url":"https://alphafold.ebi.ac.uk/files/AF-P28288-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P28288-F1-predicted_aligned_error_v6.png","plddt_mean":82.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ABCD3","jax_strain_url":"https://www.jax.org/strain/search?query=ABCD3"},"sequence":{"accession":"P28288","fasta_url":"https://rest.uniprot.org/uniprotkb/P28288.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P28288/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P28288"}},"corpus_meta":[{"pmid":"30540494","id":"PMC_30540494","title":"Peroxisomes can oxidize medium- and long-chain fatty acids through a pathway involving ABCD3 and HSD17B4.","date":"2018","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/30540494","citation_count":101,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12111378","id":"PMC_12111378","title":"Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8, ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8.","date":"2002","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12111378","citation_count":95,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25168382","id":"PMC_25168382","title":"A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25168382","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24333844","id":"PMC_24333844","title":"A role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids.","date":"2013","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/24333844","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12176987","id":"PMC_12176987","title":"ATP binding/hydrolysis by and phosphorylation of peroxisomal ATP-binding cassette proteins PMP70 (ABCD3) and adrenoleukodystrophy protein (ABCD1).","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12176987","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15276650","id":"PMC_15276650","title":"Mouse liver PMP70 and ALDP: homomeric interactions prevail in vivo.","date":"2004","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/15276650","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16344115","id":"PMC_16344115","title":"Role of Pex19p in the targeting of PMP70 to peroxisome.","date":"2005","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/16344115","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17609205","id":"PMC_17609205","title":"Live cell FRET microscopy: homo- and heterodimerization of two human peroxisomal ABC transporters, the adrenoleukodystrophy protein (ALDP, ABCD1) and PMP70 (ABCD3).","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17609205","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11330039","id":"PMC_11330039","title":"The 70-kDa peroxisomal membrane protein (PMP70), an ATP-binding cassette transporter.","date":"2000","source":"Cell biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/11330039","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8583512","id":"PMC_8583512","title":"Localization of mRNAs for adrenoleukodystrophy and the 70 kDa peroxisomal (PMP70) proteins in the rat brain during post-natal development.","date":"1995","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/8583512","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20661612","id":"PMC_20661612","title":"Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes.","date":"2010","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/20661612","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11453642","id":"PMC_11453642","title":"Targeting elements in the amino-terminal part direct the human 70-kDa peroxisomal integral membrane protein (PMP70) to peroxisomes.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11453642","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34880777","id":"PMC_34880777","title":"INTS7-ABCD3 Interaction Stimulates the Proliferation and Osteoblastic Differentiation of Mouse Bone Marrow Mesenchymal Stem Cells by Suppressing Oxidative Stress.","date":"2021","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/34880777","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39068203","id":"PMC_39068203","title":"A CCG expansion in ABCD3 causes oculopharyngodistal myopathy in individuals of European ancestry.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39068203","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11883951","id":"PMC_11883951","title":"Nucleotide-induced conformational changes of PMP70, an ATP binding cassette transporter on rat liver peroxisomal membranes.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11883951","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11460719","id":"PMC_11460719","title":"Immunodetection of hepatic peroxisomal PMP70 as an indicator of peroxisomal proliferation in the mummichog, Fundulus heteroclitus.","date":"2000","source":"Marine environmental research","url":"https://pubmed.ncbi.nlm.nih.gov/11460719","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9521874","id":"PMC_9521874","title":"Genomic organization of the 70-kDa peroxisomal membrane protein gene (PXMP1).","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9521874","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20007743","id":"PMC_20007743","title":"Multiple organelle-targeting signals in the N-terminal portion of peroxisomal membrane protein PMP70.","date":"2009","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20007743","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25802834","id":"PMC_25802834","title":"Immunohistological analysis of ABCD3 expression in Caucasian and African American prostate tumors.","date":"2015","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/25802834","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9765053","id":"PMC_9765053","title":"Restoration of PEX2 peroxisome assembly defects by overexpression of PMP70.","date":"1998","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9765053","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18992293","id":"PMC_18992293","title":"PMP70 knock-down generates oxidative stress and pro-inflammatory cytokine production in C6 glial cells.","date":"2008","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/18992293","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1295880","id":"PMC_1295880","title":"Major ATPases on clofibrate-induced rat liver peroxisomes are not associated with 70 kDa peroxisomal membrane protein (PMP70).","date":"1992","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1295880","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28409470","id":"PMC_28409470","title":"Flow Cytometric Analysis of the Expression Pattern of Peroxisomal Proteins, Abcd1, Abcd2, and Abcd3 in BV-2 Murine Microglial Cells.","date":"2017","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/28409470","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15932519","id":"PMC_15932519","title":"Limkain b1, a novel human autoantigen localized to a subset of ABCD3 and PXF marked peroxisomes.","date":"2005","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15932519","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12408580","id":"PMC_12408580","title":"Effects of vehicle, diet and gender on the expression of PMP70- and CYP2K1/2M1-like proteins in the mummichog.","date":"2002","source":"Marine environmental research","url":"https://pubmed.ncbi.nlm.nih.gov/12408580","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9599016","id":"PMC_9599016","title":"Genomic organization and chromosomal localization of the human peroxisomal membrane protein-1-like protein (PXMP1-L) gene encoding a peroxisomal ABC transporter.","date":"1998","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9599016","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40229252","id":"PMC_40229252","title":"Peroxisomal membrane protein PMP70 confers drug resistance in colorectal cancer.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/40229252","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9738957","id":"PMC_9738957","title":"The mouse gene encoding the peroxisomal membrane protein 1-like protein (PXMP1-L): cDNA cloning, genomic organization and comparative expression studies.","date":"1998","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9738957","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26711236","id":"PMC_26711236","title":"The N-terminal motif of PMP70 suppresses cotranslational targeting to the endoplasmic reticulum.","date":"2015","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26711236","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31230922","id":"PMC_31230922","title":"Initiation of the ABCD3-I algorithm for expediated evaluation of transient ischemic attack patients in an emergency department.","date":"2019","source":"The American journal of emergency medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31230922","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8411712","id":"PMC_8411712","title":"[PMP70, the 70-kDa peroxisomal membrane protein: a member of the ATP-binding cassette transporters].","date":"1993","source":"Nihon rinsho. Japanese journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/8411712","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39929145","id":"PMC_39929145","title":"Quality control of ABCD3 by the VCP-FAF2 complex suppresses excessive pexophagy.","date":"2025","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/39929145","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40668324","id":"PMC_40668324","title":"Mechanism of ABCD3 inhibiting colorectal cancer progression by regulating Wnt/β-catenin.","date":"2025","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/40668324","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40937863","id":"PMC_40937863","title":"A-to-I editing of miR-579-3p exacerbates neonatal hypoxic-ischemic brain injury via regulation of ABCD3-dependent lipid metabolism in astrocytes.","date":"2025","source":"Neurological research","url":"https://pubmed.ncbi.nlm.nih.gov/40937863","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30663969","id":"PMC_30663969","title":"TIA patients with higher ABCD3-I scores are prone to a higher incidence of intracranial stenosis, unstable carotid plaques and multiple-vessel involvement.","date":"2018","source":"Functional neurology","url":"https://pubmed.ncbi.nlm.nih.gov/30663969","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.05.21.655323","title":"Molecular mechanism of substrate transport by human peroxisomal ABCD3","date":"2025-05-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.21.655323","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.09.24.614749","title":"The p97-UBXD8 complex maintains peroxisome abundance by suppressing pexophagy","date":"2024-09-27","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.24.614749","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"9024663","id":"PMC_9024663","title":"A new class of membrane-bound chemokine with a CX3C motif.","date":"1997","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9024663","citation_count":1651,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9390561","id":"PMC_9390561","title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.","date":"1997","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9390561","citation_count":1173,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12714508","id":"PMC_12714508","title":"The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12714508","citation_count":603,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9826729","id":"PMC_9826729","title":"Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9826729","citation_count":569,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9177350","id":"PMC_9177350","title":"Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation.","date":"1997","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9177350","citation_count":535,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11495925","id":"PMC_11495925","title":"Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11495925","citation_count":533,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20920788","id":"PMC_20920788","title":"Regulation of tau pathology by the microglial fractalkine receptor.","date":"2010","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/20920788","citation_count":523,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12810688","id":"PMC_12810688","title":"Fractalkine preferentially mediates arrest and migration of CD16+ monocytes.","date":"2003","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12810688","citation_count":449,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18799722","id":"PMC_18799722","title":"CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18799722","citation_count":371,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10869418","id":"PMC_10869418","title":"Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10869418","citation_count":321,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10652441","id":"PMC_10652441","title":"Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation.","date":"2000","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/10652441","citation_count":305,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20018408","id":"PMC_20018408","title":"Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats.","date":"2009","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/20018408","citation_count":289,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24352739","id":"PMC_24352739","title":"Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage.","date":"2013","source":"Open biology","url":"https://pubmed.ncbi.nlm.nih.gov/24352739","citation_count":278,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10899174","id":"PMC_10899174","title":"Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage.","date":"2000","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10899174","citation_count":262,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12055230","id":"PMC_12055230","title":"Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12055230","citation_count":261,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10415068","id":"PMC_10415068","title":"Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10415068","citation_count":260,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12969992","id":"PMC_12969992","title":"Fractalkine in vascular biology: from basic research to clinical disease.","date":"2003","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12969992","citation_count":258,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10731151","id":"PMC_10731151","title":"Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.","date":"2000","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10731151","citation_count":257,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9726990","id":"PMC_9726990","title":"Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9726990","citation_count":242,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25745166","id":"PMC_25745166","title":"Structural biology. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor.","date":"2015","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/25745166","citation_count":235,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12016106","id":"PMC_12016106","title":"CX(3)C chemokine fractalkine in pulmonary arterial hypertension.","date":"2002","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12016106","citation_count":205,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12125082","id":"PMC_12125082","title":"Fractalkine and fractalkine receptors in human neurons and glial cells.","date":"2002","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/12125082","citation_count":191,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10187784","id":"PMC_10187784","title":"Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10187784","citation_count":185,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16877565","id":"PMC_16877565","title":"Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways.","date":"2006","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16877565","citation_count":167,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":18816,"output_tokens":3903,"usd":0.057496},"stage2":{"model":"claude-opus-4-6","input_tokens":7353,"output_tokens":3069,"usd":0.170235},"total_usd":0.517709,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":32314,"output_tokens":6055,"usd":0.093883},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9491,"output_tokens":3331,"usd":0.196095}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structures of full-length human ABCD3 in apo and phytanoyl-CoA-bound states (3.33 Å and 3.13 Å) reveal that substrate binding brings nucleotide-binding domains closer together, stimulating ATPase activity via substrate-induced conformational change — establishing the transport mechanism for peroxisomal import of branched-chain fatty acid CoA thioesters.\",\n      \"method\": \"Cryo-EM structure determination + in vitro ATPase biochemical assay\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structures in two states with orthogonal biochemical ATPase validation in single rigorous study\",\n      \"pmids\": [\"bio_10.1101_2025.05.21.655323\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ABCD3 is essential for the transport of branched-chain fatty acids (pristanic acid) and C27 bile acid intermediates into peroxisomes; loss of ABCD3 in a patient and in Abcd3-/- mice results in accumulation of C27-bile acid intermediates and reduced C24 bile acids, demonstrating a required role in bile acid biosynthesis.\",\n      \"method\": \"Patient fibroblast metabolic studies, Abcd3 knockout mouse model with bile acid and fatty acid profiling\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — convergent evidence from human patient and knockout mouse model with multiple metabolic readouts\",\n      \"pmids\": [\"25168382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ABCD3 functions as a homodimer and transports long-chain unsaturated, long branched-chain, and long-chain dicarboxylic fatty acid CoA esters into peroxisomes with distinct substrate preference from ABCD1 and ABCD2; rescue of pxa1/pxa2Δ yeast confirms homodimer functionality.\",\n      \"method\": \"Yeast complementation assay (pxa1/pxa2Δ mutant rescue), fatty acid oxidation measurements with diverse substrates\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic complementation in yeast plus substrate specificity profiling with multiple fatty acids\",\n      \"pmids\": [\"24333844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ABCD3 and HSD17B4 (D-bifunctional protein) are essential for peroxisomal oxidation of medium- and long-chain fatty acids (lauric and palmitic acid), including acylcarnitine substrates; ABCD3 KO HEK-293 cells and Hsd17b4 KO mice demonstrate peroxisomes can handle acylcarnitines via this pathway.\",\n      \"method\": \"CRISPR/Cas9 KO cell lines (single and double), pharmacological inhibition of CPT2, acylcarnitine profiling in vitro and in Hsd17b4 KO mice\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple KO lines with orthogonal pharmacological inhibition, confirmed in vivo in mouse model\",\n      \"pmids\": [\"30540494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ABCD3 (PMP70) binds ATP tightly in the absence of Mg2+, hydrolyzes ATP to ADP in the presence of Mg2+ with ADP release allowing turnover, and is phosphorylated at a tyrosine residue(s); these activities regulate fatty acid transport into peroxisomes.\",\n      \"method\": \"Photoaffinity labeling with 8-azido-[α-32P]ATP and 8-azido-[γ-32P]ATP on rat liver peroxisomes, immunoprecipitation, vanadate trapping experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 in vitro biochemical assay on native peroxisomes, single study\",\n      \"pmids\": [\"12176987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mouse liver PMP70 (ABCD3) forms exclusively homomeric complexes in vivo; no evidence of heterodimers with ALDP or accessory proteins was found in purified or immunoprecipitated PMP70 complexes.\",\n      \"method\": \"Two-step affinity purification of PMP70 complex from mouse liver; preparative immunoprecipitation of ALDP complex; protein identification\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal purification and immunoprecipitation from native tissue, but single lab\",\n      \"pmids\": [\"15276650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In living cells, ABCD3 (PMP70) forms both homodimers and heterodimers with ALDP (ABCD1) at the peroxisomal membrane, with the C-terminal 87 amino acids of ALDP being the primary domain mediating these interactions and the N-terminal transmembrane region having an additional stabilizing role.\",\n      \"method\": \"FRET microscopy in intact living cells using fluorescent fusion proteins; deletion construct analysis; statistical validation by Kolmogorov-Smirnov statistics and probability distribution shift analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — live-cell FRET is a direct protein-interaction method in physiological context, with domain mapping and rigorous statistical validation\",\n      \"pmids\": [\"17609205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Pex19p acts as a co-translational chaperone for PMP70 targeting to peroxisomes; interaction requires the N-terminal 61 amino acids and the region around TMD6 of PMP70, and deletion of these regions prevents peroxisomal localization.\",\n      \"method\": \"In vitro translation in presence/absence of purified Pex19p; co-immunoprecipitation; GFP-fusion localization studies in CHO cells\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (in vitro co-IP, deletion mapping, cell localization) in single study\",\n      \"pmids\": [\"16344115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ATP binding to PMP70 induces conformational changes at the boundary between the transmembrane and nucleotide-binding domains and in the helical domain between Walker A and B motifs; MgATP and MgADP stabilize a C-terminal 30-kDa fragment, and PMP70 exists as a dimer on peroxisomal membranes.\",\n      \"method\": \"Limited trypsin digestion of rat liver peroxisomes preincubated with various nucleotides; immunoblot analysis; native gel analysis of post-peroxisomal fraction\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conformational probing with multiple nucleotide conditions, but single lab and indirect method\",\n      \"pmids\": [\"11883951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PMP70 peroxisomal targeting requires cooperation of the N-terminal 80 amino acid segment (N80) and TM1-TM2 region; the N80 segment suppresses the intrinsic ER-targeting function of TM1, enabling peroxisomal localization; without N80, the full-length protein mislocalizes to the ER.\",\n      \"method\": \"EGFP-fusion constructs with systematic truncations and deletions expressed in COS cells; fluorescence microscopy localization\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic deletion mapping with live-cell localization readout, single lab\",\n      \"pmids\": [\"20007743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Peroxisomal targeting of human PMP70 depends on three targeting elements in the N-terminal region: amino acids 61–80 (cytosolic loop), the first transmembrane domain, and the second transmembrane domain; PEX19 interaction is not required for targeting.\",\n      \"method\": \"Deletion construct analysis with GFP fusions expressed in cells; fluorescence microscopy\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — systematic deletion mapping, single lab, no in vitro reconstitution\",\n      \"pmids\": [\"11453642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A 9-residue N-terminal motif of PMP70 (including Ser5) suppresses cotranslational ER targeting by the TM1 signal; Ser5Ala point mutation causes PMP70 to predominantly localize to the ER instead of peroxisomes; the motif functions via interaction with 50-kDa and 20-kDa binding factors.\",\n      \"method\": \"Point mutagenesis (Ser5Ala), GFP-fusion localization in cells, crosslinking to identify binding factors, competition with recombinant motif-GST fusion protein\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with localization readout and partial biochemical validation of binding factors, single lab\",\n      \"pmids\": [\"26711236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Overexpression of PMP70 suppresses the peroxisome assembly defect caused by PEX2 mutations in CHO cells, restoring peroxisomal biogenesis (catalase latency, localization, and VLCFA beta-oxidation); a mutant PMP70 allele from a Zellweger patient fails to rescue, indicating a functional interaction between PEX2 and PMP70 in peroxisome membrane biogenesis.\",\n      \"method\": \"Genetic suppression in PEX2-deficient CHO cell lines; catalase latency assay; immunohistochemistry; VLCFA beta-oxidation measurement\",\n      \"journal\": \"European journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with multiple functional readouts and disease allele control, single lab\",\n      \"pmids\": [\"9765053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The VCP-FAF2 (p97-UBXD8) complex prevents excessive pexophagy by regulating accumulation of ubiquitinated ABCD3; loss of FAF2/UBXD8 or inhibition of p97 increases ubiquitination of ABCD3 and triggers autophagy-dependent peroxisome degradation that can be rescued by USP30 overexpression.\",\n      \"method\": \"Quantitative proteomics, ubiquitination assays, UBXD8/p97 KO/inhibition, autophagy marker analysis, USP30 rescue experiments\",\n      \"journal\": \"Autophagy / bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches identifying ABCD3 ubiquitination as regulatory switch; peer-reviewed report plus preprint corroboration\",\n      \"pmids\": [\"39929145\", \"bio_10.1101_2024.09.24.614749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Stable RNAi knockdown of PMP70 (ABCD3) in rat C6 glial cells impairs peroxisomal beta-oxidation, increases VLCFA (hexacosenoic acid) in cholesterol esters, induces oxidative stress (elevated ROS, nitrites, TBARS), and triggers pro-inflammatory cytokine production (TNFα, IFNγ, IL-12); the oxidative phenotype is mediated via IL-12 release rather than directly by PMP70 loss.\",\n      \"method\": \"Stable RNAi knockdown cell line; peroxisomal beta-oxidation assay; VLCFA measurement; ROS/nitrite/TBARS quantification; cytokine ELISA; neutralizing antibody experiments\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — stable KD with multiple mechanistic readouts and pathway dissection using neutralizing antibodies, single lab\",\n      \"pmids\": [\"18992293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Edited miR-579-3p (A-to-I editing at position 4) directly targets ABCD3 and suppresses ABCD3-mediated β-oxidation of VLCFA in astrocytes, aggravating hypoxic-ischemic brain damage; dual-luciferase reporter assay confirmed ABCD3 as a direct target of the edited miRNA.\",\n      \"method\": \"Dual-luciferase reporter assay; ABCD3 KD in astrocytes; VLCFA measurement; OGD/R cell model; in vivo HIBD mouse model\",\n      \"journal\": \"Neurological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct target validation by reporter assay with in vitro and in vivo functional confirmation\",\n      \"pmids\": [\"40937863\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ABCD3 (PMP70) is an ATP-binding cassette half-transporter that homodimerizes in the peroxisomal membrane and uses substrate-induced apposition of its nucleotide-binding domains to stimulate ATP hydrolysis, driving import of CoA thioesters of branched-chain fatty acids, very long-chain fatty acids, dicarboxylic acids, and C27 bile acid intermediates into peroxisomes for β-oxidation and bile acid biosynthesis; its targeting to the peroxisomal membrane requires N-terminal motifs that suppress cotranslational ER import and interact with the chaperone Pex19p, and its peroxisomal abundance is regulated by VCP/p97-FAF2-mediated deubiquitination to suppress excessive pexophagy.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper before extracting discoveries.\n\n**Classification:**\n\n**KEEP (about ABCD3/PMP70 canonical protein):**\n- Papers [1]-[9], [12]-[13] (main corpus): clearly about ABCD3/PMP70\n- Paper [14]: CCG expansion in ABCD3 gene → KEEP (describes ABCD3 transcript effects)\n- Papers [15]-[18], [20]-[22], [24], [27], [29], [31]-[34], [36]-[37]: about ABCD3/PMP70\n\n**EXCLUDE — Symbol/alias collision (ABCD3-I score = clinical TIA risk score, not the gene):**\n- Main corpus [30], [35]: \"ABCD3-I\" is a clinical risk stratification tool for TIA, not the gene\n\n**EXCLUDE — Off-target (gene2pubmed additional papers about CX3CL1/fractalkine/CX3CR1):**\n- Additional papers [1]-[30]: Almost entirely about fractalkine (CX3CL1) and CX3CR1 — clear alias/symbol collision or unrelated genes. The gene2pubmed papers are overwhelmingly about CX3CL1/CX3CR1 chemokine biology, with a few generic genomics papers (MGC, GO propagation, lipid GWAS) that don't describe ABCD3 mechanism.\n\n**EXCLUDE — Pure expression/biomarker (no mechanism):**\n- Main corpus [2], [11], [16], [19], [23], [25], [26], [28]: SNP catalogs, expression studies, biomarker studies without mechanistic content\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"PMP70 (ABCD3) was identified as an ATP-binding cassette (ABC) transporter localized to the peroxisomal membrane, with a domain structure comprising six transmembrane segments and a hydrophilic ATP-binding domain homologous to other ABC transporters, suggesting involvement in ATP-dependent transport across the peroxisomal membrane.\",\n      \"method\": \"cDNA cloning and hydropathy analysis of rat and human liver cDNA libraries\",\n      \"journal\": \"Nihon rinsho. Japanese journal of clinical medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — foundational cDNA cloning with structural domain identification; single lab\",\n      \"pmids\": [\"8411712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The human PMP70 gene (PXMP1/ABCD3) was mapped to chromosome 1p21-p22, spans ~65 kb with 23 exons, and its promoter contains housekeeping gene features (high GC content, Sp1 sites) but no peroxisome proliferator responsive element, distinguishing it structurally from the related ALD gene.\",\n      \"method\": \"Genomic cloning, exon-intron mapping, 5' flanking region analysis, chromosomal localization\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct genomic characterization; single lab\",\n      \"pmids\": [\"9521874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Overexpression of PMP70 (ABCD3) restores peroxisome biogenesis in PEX2-deficient CHO cell clones, as confirmed by subcellular latency of catalase, immunolocalization of catalase, and beta-oxidation of very long chain fatty acids; a Zellweger syndrome-associated mutant allele of PMP70 failed to rescue, indicating a functional interaction between PEX2 and PMP70 in peroxisome membrane assembly.\",\n      \"method\": \"Transfection rescue experiments in PEX2-mutant CHO cells; catalase latency assay; immunohistochemistry; VLCFA beta-oxidation assay\",\n      \"journal\": \"European journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal functional assays with mutant allele control; single lab but rigorous\",\n      \"pmids\": [\"9765053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"PMP70 (ABCD3) is synthesized on free polysomes and posttranslationally inserted into peroxisomal membranes, where it assembles as dimeric or oligomeric forms, consistent with a role in long-chain acyl-CoA transport across the peroxisomal membrane.\",\n      \"method\": \"Cell fractionation, immunoblot, and biochemical characterization of peroxisomal membranes\",\n      \"journal\": \"Cell biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical fractionation evidence; single review-style paper synthesizing experimental work\",\n      \"pmids\": [\"11330039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Efficient peroxisomal targeting of human PMP70 (ABCD3) requires three targeting elements in the amino-terminal region: amino acids 61–80 in the cytosol, and the first and second transmembrane domains; PEX19 interaction is not required for targeting.\",\n      \"method\": \"Expression of deletion constructs in CHO cells; immunofluorescence localization\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct localization experiments with deletion constructs; single lab\",\n      \"pmids\": [\"11453642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PMP70 (ABCD3) binds ATP tightly in the absence of Mg2+; in the presence of Mg2+, bound ATP is hydrolyzed to ADP which then dissociates, enabling ATPase turnover. PMP70 is also phosphorylated at a tyrosine residue(s). Vanadate-induced nucleotide trapping was not observed, distinguishing its mechanism from some other ABC transporters.\",\n      \"method\": \"Photoaffinity labeling of rat liver peroxisomes with 8-azido-[α-32P]ATP and 8-azido-[γ-32P]ATP; co-immunoprecipitation; Mg2+-dependent hydrolysis assay; vanadate trapping assay; phosphorylation detection\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical reconstitution with multiple nucleotide analogs and controls; rigorous mechanistic dissection\",\n      \"pmids\": [\"12176987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ATP binding to PMP70 (ABCD3) induces nucleotide-dependent conformational changes detectable by limited trypsin digestion: MgATP or MgADP stabilize a ~30 kDa C-terminal fragment spanning the helical domain between Walker A and B motifs, while MgATP-γS protects the entire protein. The C-terminal fragment forms an ~60 kDa complex consistent with PMP70 dimerization on peroxisomal membranes.\",\n      \"method\": \"Limited trypsin digestion of rat liver peroxisomes pre-incubated with various nucleotides; immunoblot with anti-C-terminal antibody; gel filtration\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro structural/conformational assay with multiple nucleotide conditions; directly links ATP hydrolysis to conformational change\",\n      \"pmids\": [\"11883951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mouse liver PMP70 (ABCD3) forms predominantly homomeric complexes in vivo; no evidence of heteromeric interactions with ALDP (ABCD1) or accessory proteins was found under normal physiological expression conditions.\",\n      \"method\": \"Two-step purification of PMP70 protein complex to homogeneity; preparative immunoprecipitation of ALDP complex; protein identification\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — protein complex purified to homogeneity from native tissue; reciprocal IP; strong evidence for homodimerization\",\n      \"pmids\": [\"15276650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Pex19p acts as a chaperone for PMP70 (ABCD3) during synthesis, binding co-translationally to prevent aggregation; the interaction requires both the N-terminal 61 amino acids and the region around TMD6 of PMP70, and deletion of either region abolishes peroxisomal localization.\",\n      \"method\": \"In vitro translation with purified Pex19p; co-immunoprecipitation; GFP fusion constructs expressed in CHO cells; immunofluorescence localization\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro reconstitution of chaperone interaction combined with cell-based localization assays; multiple deletion constructs\",\n      \"pmids\": [\"16344115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In living cells, ALDP (ABCD1) and PMP70 (ABCD3) form both homodimers and heterodimers (ALDP/PMP70) in the peroxisomal membrane, with ALDP homodimers predominating. The last 87 C-terminal amino acids of ALDP constitute the primary dimerization domain, with the N-terminal transmembrane region providing additional stabilization of ALDP homodimers.\",\n      \"method\": \"FRET microscopy in intact living cells; probability distribution shift analysis; Kolmogorov-Smirnov statistics; C-terminal deletion constructs of ALDP\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — live-cell FRET with rigorous statistical analysis; circumvents in vitro artifacts; multiple deletion constructs\",\n      \"pmids\": [\"17609205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Knockdown of PMP70 (ABCD3) in rat C6 glial cells impairs peroxisomal beta-oxidation and causes oxidative stress (elevated nitric oxide via iNOS upregulation, increased superoxide and lipid peroxidation, altered antioxidant enzyme activities). The resulting oxidative phenotype is dependent on IL-12 release rather than being a direct consequence of PMP70 loss.\",\n      \"method\": \"Stable RNAi knockdown of ABCD3 in C6 cells; nitrite measurement; superoxide and TBARS assays; antioxidant enzyme activity; cytokine quantification; neutralizing antibodies against IL-12\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — stable KD with multiple phenotypic readouts and pathway dissection using neutralizing antibodies; single lab\",\n      \"pmids\": [\"18992293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The N-terminal 80-amino-acid segment (N80) of PMP70 (ABCD3) is critical for suppressing the intrinsic ER-targeting function of the TM1 segment: TM1 alone directs protein to the ER, the N80 segment alone targets mitochondrial outer membrane, but together N80 + TM1-TM2 directs exclusively to peroxisomes. Cooperation of multiple organelle-targeting signals enables correct peroxisomal localization.\",\n      \"method\": \"EGFP fusion constructs expressed in COS cells; fluorescence microscopy; deletion and domain-swap analysis\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — systematic domain analysis with multiple constructs and direct imaging; single lab\",\n      \"pmids\": [\"20007743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ABCD3 (PMP70) transports long-chain unsaturated, long branched-chain, and long-chain dicarboxylic fatty acids (as CoA esters) into peroxisomes for beta-oxidation, with a substrate preference distinct from ABCD1 (favoring C24:0/C26:0) and ABCD2 (favoring C22:0/C22:6). Each peroxisomal half-transporter can function as a homodimer, demonstrated by partial rescue of the pxa1/pxa2Δ yeast mutant by human ABCD3.\",\n      \"method\": \"Functional complementation of pxa1/pxa2Δ yeast mutant; fatty acid oxidation measurements with multiple substrates in yeast expressing human ABCD transporters\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in yeast combined with comprehensive substrate specificity profiling; mechanistically rigorous\",\n      \"pmids\": [\"24333844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ABCD3 is essential for peroxisomal transport of branched-chain fatty acids (e.g., pristanic acid) and C27 bile acid intermediates, making it a crucial step in bile acid biosynthesis. Loss of ABCD3 (patient with truncating mutation p.Y635NfsX1; Abcd3−/− mice) causes accumulation of C27-bile acid intermediates, reduced C24 bile acids, and reduced pristanic acid beta-oxidation, with peroxisomes remaining import-competent but reduced in number and enlarged.\",\n      \"method\": \"Patient fibroblast analysis; genetic analysis; Abcd3−/− mouse model; bile acid profiling in liver, bile and intestine; phytol loading assay; peroxisomal beta-oxidation assays\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human patient + mouse KO model with multiple biochemical endpoints; independently validated in two biological systems\",\n      \"pmids\": [\"25168382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A short N-terminal sequence of nine residues in PMP70 (ABCD3), specifically Ser5, acts as an ER-targeting suppressor by blocking the intrinsic ER-targeting signal of the TM1 segment. The Ser5Ala point mutation causes PMP70 to localize predominantly to the ER. Two proteins of ~50 kDa and ~20 kDa crosslink with this suppressor motif.\",\n      \"method\": \"Point mutagenesis (Ser5Ala); fluorescence microscopy in COS cells; crosslinking to identify binding proteins; recombinant motif-GST competition assay\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — point mutagenesis with direct localization readout and crosslinking; single lab\",\n      \"pmids\": [\"26711236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Peroxisomes can oxidize medium- and long-chain fatty acids (lauric and palmitic acid) through a pathway requiring both ABCD3 and HSD17B4 (D-bifunctional protein). Peroxisomes accept acylcarnitines (not only acyl-CoAs) as substrates. This peroxisomal pathway becomes physiologically relevant when mitochondrial FAO is defective, as demonstrated in vivo by altered plasma acylcarnitine profiles in Hsd17b4 KO mice after acute CPT2 inhibition.\",\n      \"method\": \"CRISPR-Cas9 single and double KO of ABCD3, HSD17B4, and CPT2 in HEK-293 cells; pharmacological CPT2 inhibition; acylcarnitine profiling; Hsd17b4 KO mouse model with CPT2 inhibition\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR KO with multiple single/double KO cell lines plus in vivo mouse validation; two independent experimental systems\",\n      \"pmids\": [\"30540494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ABCD3 interacts with INTS7 in bone marrow mesenchymal stem cells; this INTS7-ABCD3 interaction promotes BM-MSC proliferation and osteoblastic differentiation while suppressing adipogenic differentiation, through suppression of oxidative stress (reduced ROS and γ-H2AX, maintained antioxidant levels). HDLBP, also identified as an ABCD3 interactor, did not share these functions.\",\n      \"method\": \"Co-immunoprecipitation (INTS7-ABCD3 interaction); siRNA knockdown of INTS7, ABCD3, and HDLBP; ROS quantification; γ-H2AX measurement; Alizarin Red S and Oil Red O staining for differentiation; apoptosis assays\",\n      \"journal\": \"Frontiers in physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP identifies interaction; functional KD with multiple readouts; single lab\",\n      \"pmids\": [\"34880777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CCG repeat expansions in ABCD3 (118–694 repeats) cause oculopharyngodistal myopathy (OPDM) in individuals of European ancestry; ABCD3 transcript appears upregulated in fibroblasts and skeletal muscle from affected individuals, suggesting gain-of-function RNA toxicity as a disease mechanism.\",\n      \"method\": \"Repeat expansion genotyping; long-read sequencing; RT-qPCR of ABCD3 transcript levels in patient fibroblasts and skeletal muscle\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — genetic identification with transcript upregulation evidence; mechanism (RNA toxicity) is inferred rather than directly proven\",\n      \"pmids\": [\"39068203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The VCP-FAF2 complex prevents excessive pexophagy by regulating the accumulation of ubiquitinated ABCD3; loss of FAF2 or inhibition of VCP increases ubiquitination of ABCD3 and drives peroxisome degradation via selective autophagy (pexophagy), which can be rescued by USP30 overexpression or depletion of autophagy receptors.\",\n      \"method\": \"VCP inhibition and FAF2 knockout; quantitative proteomics; ubiquitination assays for ABCD3; autophagy flux assays; USP30 overexpression rescue\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological perturbation with proteomic validation; mechanistically links ABCD3 ubiquitination to pexophagy\",\n      \"pmids\": [\"39929145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ABCD3 depletion in colorectal cancer cells reduces cell viability, proliferation, invasion, and migration; mechanistically, ABCD3 suppresses Wnt/β-catenin signaling, and its loss activates this pathway to promote malignant behavior. ABCD3 protein also protects against excessive lipid peroxidation and maintains neutral lipid and lipid droplet homeostasis in cancer cells.\",\n      \"method\": \"siRNA knockdown; CCK-8 proliferation assay; Transwell invasion/migration assay; Western blot; TCGA/WGCNA bioinformatics; lipid peroxidation assays; neutral lipid staining\",\n      \"journal\": \"Molecular biology reports / Cell death & disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — KD with phenotypic readouts and pathway inference; Wnt/β-catenin link is functional but molecular mechanism not directly established\",\n      \"pmids\": [\"40668324\", \"40229252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structures of full-length human ABCD3 in apo (3.33 Å) and phytanoyl-CoA-bound (3.13 Å) states reveal that substrate binding brings the two nucleotide-binding domains (NBDs) closer together, mechanistically explaining how substrate binding stimulates ATPase activity. Biochemical assays confirm substrate-dependent ATPase activation.\",\n      \"method\": \"Cryo-EM structure determination; ATPase activity biochemical assay; structural comparison of apo vs. substrate-bound conformations\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structures of both states plus functional ATPase assay; rigorous mechanistic study\",\n      \"pmids\": [\"bio_10.1101_2025.05.21.655323\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Edited miR-579-3p (A-to-I editing) acquires ABCD3 as a novel target, suppressing ABCD3-mediated VLCFA beta-oxidation in astrocytes and thereby exacerbating hypoxic-ischemic brain damage; wild-type miR-579-3p does not target ABCD3.\",\n      \"method\": \"Dual-luciferase reporter assay confirming miRNA-ABCD3 3'UTR interaction; VLCFA measurement by ELISA; Western blot and RT-qPCR; in vivo HIBD mouse model\",\n      \"journal\": \"Neurological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — luciferase reporter validates direct miRNA-ABCD3 targeting; in vivo confirmation; single lab\",\n      \"pmids\": [\"40937863\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ABCD3 (PMP70) is a peroxisomal membrane half-ABC transporter that homodimerizes (and can heterodimerize with ABCD1) to transport branched-chain fatty acids, long-chain dicarboxylic acids, and C27 bile acid intermediates as CoA esters into the peroxisome for beta-oxidation and bile acid biosynthesis; substrate binding induces NBD dimerization to stimulate ATP hydrolysis (now structurally resolved by cryo-EM), its peroxisomal targeting depends on an N-terminal ER-suppressor motif and Pex19p chaperone interaction, and its protein quality is controlled by VCP-FAF2-mediated regulation of ubiquitination to prevent excessive pexophagy.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ABCD3 (PMP70) is a peroxisomal membrane ATP-binding cassette half-transporter that homodimerizes to import CoA thioesters of branched-chain fatty acids, long-chain unsaturated and dicarboxylic fatty acids, and C27 bile acid intermediates into peroxisomes for β-oxidation and bile acid biosynthesis [PMID:24333844, PMID:25168382, PMID:30540494]. Substrate binding (e.g., phytanoyl-CoA) induces apposition of the nucleotide-binding domains, stimulating ATPase activity to drive the transport cycle [PMID:12176987, PMID:11883951]. Peroxisomal targeting of ABCD3 depends on cooperation between an N-terminal motif (including Ser5) that suppresses cotranslational ER insertion of its first transmembrane domain, and interaction with the chaperone Pex19p [PMID:16344115, PMID:20007743, PMID:26711236]. Loss-of-function mutations in ABCD3 cause accumulation of C27 bile acid intermediates and branched-chain fatty acids, establishing it as a disease gene for a peroxisomal fatty acid oxidation disorder [PMID:25168382].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Overexpression of PMP70 could suppress peroxisome assembly defects caused by PEX2 mutations, indicating a functional link between PMP70 and peroxisome membrane biogenesis beyond its transporter role.\",\n      \"evidence\": \"Genetic suppression assay in PEX2-deficient CHO cells with catalase latency, immunohistochemistry, and VLCFA β-oxidation readouts\",\n      \"pmids\": [\"9765053\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of genetic suppression unclear — direct PEX2–PMP70 interaction not demonstrated\", \"Single lab finding without independent replication\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Mapping of targeting determinants established that three N-terminal elements — a cytosolic loop (aa 61–80) and two transmembrane domains — are required for peroxisomal localization, opening questions about the chaperone requirements for PMP targeting.\",\n      \"evidence\": \"GFP-fusion deletion constructs expressed in cells with fluorescence microscopy\",\n      \"pmids\": [\"11453642\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab study without in vitro reconstitution\", \"Conflict with later studies on Pex19p requirement remained unresolved at this point\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Biochemical characterization revealed that ABCD3 binds and hydrolyzes ATP, that nucleotide binding induces conformational changes at the transmembrane–NBD boundary, and that the protein exists as a dimer on peroxisomal membranes — establishing the basic enzymology of the transporter.\",\n      \"evidence\": \"Photoaffinity labeling with azido-ATP, vanadate trapping, limited trypsin digestion, and native gel analysis on rat liver peroxisomes\",\n      \"pmids\": [\"12176987\", \"11883951\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No reconstituted system to measure vectorial transport directly\", \"Tyrosine phosphorylation site(s) not mapped\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of Pex19p as a co-translational chaperone for PMP70 resolved how the transporter is correctly routed to peroxisomes, with the N-terminal 61 amino acids and TMD6 region serving as Pex19p-binding determinants.\",\n      \"evidence\": \"In vitro translation with purified Pex19p, co-immunoprecipitation, and GFP-fusion localization in CHO cells\",\n      \"pmids\": [\"16344115\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of additional membrane insertion machinery at the peroxisome not addressed\", \"Relative contributions of Pex19p vs. other factors to in vivo targeting not quantified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Live-cell FRET demonstrated that ABCD3 forms both homodimers and heterodimers with ABCD1 (ALDP) in intact cells, mapping the dimerization interface to the C-terminal 87 amino acids of ALDP — refining the oligomeric landscape of peroxisomal ABC transporters.\",\n      \"evidence\": \"FRET microscopy with fluorescent fusion proteins and deletion constructs in living cells\",\n      \"pmids\": [\"17609205\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional significance of ABCD3–ABCD1 heterodimers versus homodimers in substrate transport not determined\", \"Earlier immunopurification found only homodimers in mouse liver, suggesting heterodimer abundance may be context-dependent\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"A refined targeting model showed that the N-terminal 80-residue segment suppresses the intrinsic ER-targeting signal of TM1, explaining how ABCD3 avoids cotranslational ER insertion and is routed to peroxisomes.\",\n      \"evidence\": \"Systematic EGFP-fusion truncations and deletions in COS cells with fluorescence microscopy\",\n      \"pmids\": [\"20007743\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which N80 suppresses ER signal not defined at molecular level\", \"Single lab; no reconstitution in cell-free system\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Yeast complementation definitively demonstrated that ABCD3 functions as a homodimer with substrate specificity for branched-chain, long-chain unsaturated, and dicarboxylic fatty acid CoA esters — distinct from ABCD1 and ABCD2.\",\n      \"evidence\": \"Rescue of pxa1/pxa2Δ yeast mutant plus fatty acid oxidation measurements with diverse substrates\",\n      \"pmids\": [\"24333844\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for substrate discrimination among ABCD family members unknown at this stage\", \"Yeast system may not fully recapitulate mammalian peroxisomal lipid environment\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Convergent human patient and knockout mouse data established ABCD3 as essential for import of branched-chain fatty acids and C27 bile acid intermediates, linking its loss to a Mendelian peroxisomal disorder with impaired bile acid biosynthesis.\",\n      \"evidence\": \"Metabolic profiling in patient fibroblasts and Abcd3−/− mice showing accumulation of C27 bile acid intermediates and reduced C24 bile acids\",\n      \"pmids\": [\"25168382\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Range of clinical phenotypes in human patients not fully delineated\", \"Whether compensatory upregulation of ABCD1/ABCD2 modifies phenotype not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"A 9-residue N-terminal motif centered on Ser5 was identified as a critical suppressor of ER mistargeting, with Ser5Ala mutation causing ER mislocalization and crosslinking identifying 50-kDa and 20-kDa binding factors — narrowing the targeting switch to a single residue.\",\n      \"evidence\": \"Point mutagenesis, GFP-fusion localization, crosslinking, and competition with recombinant motif-GST fusions\",\n      \"pmids\": [\"26711236\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the 50-kDa and 20-kDa binding factors not determined\", \"In vivo relevance of Ser5 mutation not tested in animal models\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"ABCD3 was shown to be required for peroxisomal oxidation of medium- and long-chain fatty acids including acylcarnitine substrates, expanding its substrate repertoire beyond CoA thioesters.\",\n      \"evidence\": \"CRISPR/Cas9 KO HEK-293 cells, CPT2 pharmacological inhibition, acylcarnitine profiling in vitro and in Hsd17b4 KO mice\",\n      \"pmids\": [\"30540494\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ABCD3 directly transports acylcarnitines or their CoA derivatives not resolved\", \"Relative contribution of ABCD3 vs other transporters for medium-chain substrates in vivo unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"The VCP/p97-FAF2 complex was identified as a pexophagy regulator acting through ABCD3 ubiquitination: loss of this complex increases ABCD3 ubiquitination and triggers autophagy-dependent peroxisome degradation, establishing ABCD3 as a key regulatory target for peroxisome quality control.\",\n      \"evidence\": \"Quantitative proteomics, ubiquitination assays, UBXD8/p97 KO and inhibition, USP30 rescue experiments\",\n      \"pmids\": [\"39929145\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the E3 ubiquitin ligase ubiquitinating ABCD3 not determined\", \"Specific ubiquitination sites on ABCD3 not mapped\", \"Whether this mechanism operates in all tissues not tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Cryo-EM structures of human ABCD3 in apo and phytanoyl-CoA-bound states revealed the structural basis of substrate-induced NBD apposition, providing the first atomic-resolution model of the ABCD3 transport cycle.\",\n      \"evidence\": \"(preprint) Cryo-EM at 3.13–3.33 Å resolution with in vitro ATPase assays\",\n      \"pmids\": [\"bio_10.1101_2025.05.21.655323\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Preprint not yet peer reviewed\", \"Outward-open and occluded intermediate states not captured\", \"Mechanism of CoA release on the luminal side not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of the E3 ligase and specific ubiquitination sites controlling ABCD3-dependent pexophagy, the structural basis for discrimination among branched-chain, dicarboxylic, and bile acid substrates, and the physiological significance of ABCD3–ABCD1 heterodimers.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No reconstituted proteoliposome transport assay for ABCD3\", \"Complete transport cycle intermediates not structurally resolved\", \"Tissue-specific regulation of ABCD3 expression and turnover largely unexplored\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 4, 8]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [1, 2, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005777\", \"supporting_discovery_ids\": [1, 2, 7, 9, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:1430728\", \"supporting_discovery_ids\": [1, 2, 3]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"complexes\": [\n      \"ABCD3 homodimer\"\n    ],\n    \"partners\": [\n      \"PEX19\",\n      \"ABCD1\",\n      \"VCP\",\n      \"FAF2\",\n      \"HSD17B4\",\n      \"PEX2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"ABCD3 (PMP70) is a peroxisomal membrane ABC half-transporter that homodimerizes to import branched-chain fatty acids, long-chain dicarboxylic acids, and C27 bile acid intermediates as CoA esters into the peroxisome for β-oxidation and bile acid biosynthesis [PMID:24333844, PMID:25168382]. ATP binding induces nucleotide-binding domain dimerization and conformational changes that drive an ATPase cycle with substrate-stimulated hydrolysis; Mg²⁺ is required for catalytic turnover, and substrate binding brings the two NBDs closer together to activate ATPase activity [PMID:12176987, PMID:11883951]. Correct peroxisomal targeting depends on an N-terminal ER-suppressor motif (notably Ser5) cooperating with the first two transmembrane domains, and on co-translational chaperoning by Pex19p, while protein quality is maintained by VCP–FAF2-mediated regulation of ABCD3 ubiquitination that prevents excessive pexophagy [PMID:26711236, PMID:16344115, PMID:39929145]. Loss-of-function mutations in ABCD3 cause accumulation of C27-bile acid intermediates and impaired pristanic acid oxidation in humans and mice, and CCG repeat expansions in ABCD3 cause oculopharyngodistal myopathy [PMID:25168382, PMID:39068203].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Identifying ABCD3 as a peroxisomal ABC transporter established the gene family context and predicted ATP-dependent transport across the peroxisomal membrane.\",\n      \"evidence\": \"cDNA cloning and hydropathy analysis from rat and human liver libraries\",\n      \"pmids\": [\"8411712\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No transport substrate identified\", \"No functional assay performed\", \"Domain architecture inferred from homology only\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Biochemical dissection of ATP binding and hydrolysis revealed that ABCD3 requires Mg²⁺ for ATPase turnover and undergoes nucleotide-dependent conformational changes consistent with a dimeric catalytic mechanism, distinguishing it from vanadate-trappable ABC transporters.\",\n      \"evidence\": \"Photoaffinity labeling with azido-ATP analogs, limited trypsinolysis with multiple nucleotides, and gel filtration of rat liver peroxisomes\",\n      \"pmids\": [\"12176987\", \"11883951\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No transport substrate identified at this stage\", \"ATPase assay performed on endogenous membranes rather than reconstituted protein\", \"Dimerization stoichiometry inferred from fragment size on gel filtration\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Purification of native PMP70 complexes from mouse liver demonstrated that ABCD3 predominantly forms homodimers in vivo, resolving the question of whether it required ABCD1 as a heterodimerization partner.\",\n      \"evidence\": \"Two-step purification to homogeneity and reciprocal immunoprecipitation of ALDP complexes from mouse liver\",\n      \"pmids\": [\"15276650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Heterodimerization with ABCD1 not excluded under all conditions\", \"Functional significance of homodimer versus heterodimer not tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Establishing that Pex19p chaperones nascent ABCD3 co-translationally to prevent aggregation answered how a polytopic membrane protein reaches the peroxisome post-translationally.\",\n      \"evidence\": \"In vitro translation with purified Pex19p, co-immunoprecipitation, and GFP-fusion localization in CHO cells\",\n      \"pmids\": [\"16344115\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the membrane insertion machinery at the peroxisome not resolved\", \"Whether Pex19p is strictly required or facilitatory was debated across studies\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Live-cell FRET confirmed ABCD3 forms both homodimers and heterodimers with ABCD1 in intact peroxisomal membranes, refining the earlier homodimer-only model and raising questions about heterodimer-specific substrate channeling.\",\n      \"evidence\": \"FRET microscopy with statistical probability-distribution analysis in living cells; C-terminal deletion mapping of dimerization domains\",\n      \"pmids\": [\"17609205\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequences of heterodimerization not determined\", \"Relative abundance of heterodimers versus homodimers in different tissues unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Systematic domain-swap experiments revealed that the N-terminal 80-residue segment suppresses an intrinsic ER-targeting signal in TM1, explaining how ABCD3 escapes the secretory pathway to reach peroxisomes.\",\n      \"evidence\": \"EGFP fusion constructs with deletions and domain swaps expressed in COS cells; fluorescence microscopy\",\n      \"pmids\": [\"20007743\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cytosolic factors recognizing the suppressor motif not identified at this stage\", \"Mechanism by which TM1 alone targets ER not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Functional complementation of yeast pxa1/pxa2Δ mutants with human ABCD3 defined its substrate preference for branched-chain, long-chain unsaturated, and dicarboxylic fatty acyl-CoAs, distinguishing ABCD3 from ABCD1 and ABCD2.\",\n      \"evidence\": \"β-oxidation assays with multiple fatty acid substrates in yeast expressing individual human ABCD transporters\",\n      \"pmids\": [\"24333844\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transport assay with purified protein not performed\", \"In vivo substrate hierarchy in mammals not established\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Human patient and mouse knockout studies proved ABCD3 is essential for peroxisomal import of C27 bile acid intermediates and pristanic acid, linking ABCD3 loss to a defined metabolic disease with bile acid accumulation.\",\n      \"evidence\": \"Fibroblast analysis from patient with truncating ABCD3 mutation; Abcd3−/− mice with bile acid profiling and phytol loading\",\n      \"pmids\": [\"25168382\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full clinical spectrum of ABCD3 deficiency not delineated\", \"Whether residual transport occurs via ABCD1/ABCD2 compensation not quantified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Pinpointing Ser5 as the critical residue in the ER-suppressor motif showed that a single amino acid substitution reroutes ABCD3 to the ER, narrowing the targeting code to a defined molecular determinant.\",\n      \"evidence\": \"Ser5Ala point mutagenesis with fluorescence microscopy in COS cells; crosslinking to identify ~50 kDa and ~20 kDa binding partners\",\n      \"pmids\": [\"26711236\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the ~50 kDa and ~20 kDa crosslinked proteins not determined\", \"Whether Ser5 phosphorylation regulates targeting not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrating that peroxisomes accept acylcarnitines via ABCD3/HSD17B4 and compensate for mitochondrial FAO deficiency expanded the physiological scope of ABCD3 from bile acid/branched-chain metabolism to medium/long-chain fatty acid oxidation.\",\n      \"evidence\": \"CRISPR-Cas9 single and double KO in HEK-293 cells; CPT2 inhibition; acylcarnitine profiling; Hsd17b4 KO mouse with CPT2 inhibition\",\n      \"pmids\": [\"30540494\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ABCD3 directly transports acylcarnitines or CoA-converted intermediates not resolved\", \"Tissue specificity of this compensatory pathway not fully mapped\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery of CCG repeat expansions in ABCD3 as a cause of oculopharyngodistal myopathy established a second distinct disease mechanism (repeat expansion/RNA toxicity) separate from loss-of-function metabolic disease.\",\n      \"evidence\": \"Repeat expansion genotyping, long-read sequencing, RT-qPCR of ABCD3 transcript in patient fibroblasts and muscle\",\n      \"pmids\": [\"39068203\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"RNA toxicity mechanism not directly demonstrated\", \"Whether ABCD3 protein function is altered by repeat expansion not tested\", \"Replication in larger cohorts needed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"VCP–FAF2-mediated regulation of ABCD3 ubiquitination was shown to control peroxisome abundance by preventing excessive pexophagy, establishing ABCD3 as a key ubiquitination target in peroxisome quality control.\",\n      \"evidence\": \"VCP inhibition and FAF2 KO with quantitative proteomics, ubiquitination assays, and USP30 rescue\",\n      \"pmids\": [\"39929145\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific ubiquitination sites on ABCD3 not mapped\", \"Whether ubiquitinated ABCD3 is directly recognized by autophagy receptors not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Cryo-EM structures of apo and phytanoyl-CoA-bound ABCD3 revealed that substrate binding brings the two NBDs closer together, providing the structural basis for substrate-stimulated ATPase activity and completing the transport cycle model.\",\n      \"evidence\": \"Cryo-EM at 3.1–3.3 Å resolution of full-length human ABCD3; ATPase assay (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.05.21.655323\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structures of nucleotide-bound and post-hydrolysis states not yet captured\", \"Mechanism of substrate release into the peroxisomal lumen not resolved\", \"Preprint — awaits peer review\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of the complete transport cycle (nucleotide-bound and outward-open states), the identity of cytosolic factors that interact with the Ser5 ER-suppressor motif, the functional significance of ABCD1–ABCD3 heterodimers versus homodimers in different tissues, and the molecular mechanism of RNA toxicity in ABCD3 repeat expansion disease.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Full transport cycle intermediates not structurally resolved\", \"Tissue-specific roles of heterodimer versus homodimer unknown\", \"RNA toxicity mechanism in OPDM not directly demonstrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [5, 6, 20]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [12, 13, 15]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [5, 6, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005777\", \"supporting_discovery_ids\": [0, 3, 4, 7, 8, 9, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [12, 13, 15]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [5, 6, 12, 13, 20]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [18]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [2, 18]}\n    ],\n    \"complexes\": [\n      \"ABCD3 homodimer\",\n      \"ABCD1-ABCD3 heterodimer\"\n    ],\n    \"partners\": [\n      \"ABCD1\",\n      \"PEX19\",\n      \"PEX2\",\n      \"HSD17B4\",\n      \"VCP\",\n      \"FAF2\",\n      \"USP30\",\n      \"INTS7\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}